Scope of the project:
We are offering an exciting scientific position in the field of tumor immunology in a highly clinically relevant research area. The focus of the group Immunopharmacology (Head: PD Dr. Sebastian Kobold) is the development of new anti-tumoral immunotherapies. The project will focus on the development of a novel strategy for cellular therapy of cancer. All projects are embedded in the doctorate program i-Target (Immunotargeting of Cancer) of the Elite Network of Bavaria (www.immunotarget.de) and the Marie-Sklodowska Curie Network IMMUTRAIN, funded by the European Union.
Application deadline: 31st of July 2017